The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of FDG-PET/CT and gastrointestinal endoscopy in the staging of diffuse large B-cell lymphoma (DLBCL): Expanded data.
 
Tadahiro Honda
No Relationships to Disclose
 
Dai Maruyama
Honoraria - Celgene; Chugai Pharma; Eisai; Fujifilm; Janssen; Kyowa Hakko Kirin; Mochida Pharmaceutical Co. Ltd.; Mundipharma; Nippon Kayaku; Ono Pharmaceutical; Sanofi; Takeda
 
Hiroaki Kurihara
No Relationships to Disclose
 
Akiko Miyagi Maeshima
No Relationships to Disclose
 
Sayako Yuda
No Relationships to Disclose
 
Kosuke Toyoda
Honoraria - Chugai Pharma
 
Nobuhiko Yamauchi
No Relationships to Disclose
 
Shinichi Makita
Honoraria - Chugai Pharma
 
Suguru Fukuhara
Honoraria - Chugai Pharma
Research Funding - Ono Pharmaceutical (Inst)
 
Wataru Munakata
No Relationships to Disclose
 
Yukio Kobayashi
Honoraria - Boehringer Ingelheim
Research Funding - Amgen; ARIAD; Astellas Pharma; Celgene; GlaxoSmithKline; Kyowa Hakko Kirin; Otsuka; Pfizer; Sanofi; SymBio Pharmaceuticals
 
Hirokazu Taniguchi
No Relationships to Disclose
 
Yutaka Saito
No Relationships to Disclose
 
Kensei Tobinai
Honoraria - Eisai; Mundipharma; Spectrum Pharmaceuticals; Takeda; Zenyaku Kogyo
Research Funding - Abbvie (Inst); Celgene (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Mundipharma (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst); Takeda (Inst)